Financial statements Abba Pharm
Balance sheet data of ABBA PHARM
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|---|---|---|---|---|
Total assets | 784 056,52 | 647 496,26 | 495 185,88 | 345 487,84 | 283 786,39 |
A. Fixed assets | 134 642,70 | 219 687,80 | 0,00 | 0,00 | 0,00 |
B. Current assets | 649 413,82 | 427 808,46 | 495 185,88 | 345 487,84 | 283 786,39 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 784 056,52 | 647 496,26 | 495 185,88 | 345 487,84 | 283 786,39 |
A. Equity | 665 630,60 | 485 028,00 | 138 324,30 | 115 372,06 | 19 714,20 |
B. Liabilities and provisions for liabilities | 118 425,92 | 162 468,26 | 356 861,58 | 230 115,78 | 264 072,19 |
I. Long-term liabilities | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.